Literature DB >> 7090841

The distribution and metabolism of 14C-labelled tamoxifen in spayed female mice.

N Wilking, L E Appelgren, K Carlström, A Pousette, N O Theve.   

Abstract

The distribution and metabolism of 14C-tamoxifen (a non-steroidal triaryl ethylene anti-oestrogen) have been investigated in ovarieectomized mice. The autoradiograms showed accumulation of radioactivity in the liver and the bile as an indication of an excretory pathway, but a rapid and high accumulation was also seen in the lung and the adrenals, organs normally not considered as target organs for tamoxifen. The liver and sebaceous glands could be detected on the autoradiograms up to fourteen days after a single intravenous dose. However, in most organs the amount of retained radioactivity was very low after 24 hours. By using the autoradiograms as a guideline a metabolic study was performed. High concentrations of unmetabolized tamoxifen was detected in the lung and the adrenals as well as in the pancreas. Relatively high amounts of a compound tentatively identified as 4-hydroxy-tamoxifen were present in the pancreas and the liver and there were also indications for the presence of N-desmethyl-tamoxifen in these tissues. These metabolites are considered to possess anti-oestrogenic activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7090841     DOI: 10.1111/j.1600-0773.1982.tb00958.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  7 in total

1.  Radiosensitization of human glioma cells by tamoxifen is associated with the inhibition of PKC-ι activity in vitro.

Authors:  Lei Yang; Xiaopeng Yuan; Jie Wang; Cheng Gu; Haowen Zhang; Jiahua Yu; Fenju Liu
Journal:  Oncol Lett       Date:  2015-05-11       Impact factor: 2.967

Review 2.  Pharmacokinetics of selective estrogen receptor modulators.

Authors:  Karla C Morello; Gregory T Wurz; Michael W DeGregorio
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Targeting tamoxifen to breast cancer xenograft tumours: preclinical efficacy of folate-attached nanoparticles based on alginate-cysteine/disulphide-bond-reduced albumin.

Authors:  A Martínez; E Muñiz; C Teijón; I Iglesias; J M Teijón; M D Blanco
Journal:  Pharm Res       Date:  2013-11-12       Impact factor: 4.200

Review 4.  Biology of pancreatic cancer.

Authors:  G J Poston; J Gillespie; P J Guillou
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

Review 5.  Neuropsychological sequelae of non-central nervous system cancer and cancer therapy.

Authors:  Jeffrey S Wefel; Mariana E Witgert; Christina A Meyers
Journal:  Neuropsychol Rev       Date:  2008-04-16       Impact factor: 7.444

6.  Pharmacokinetics of droloxifene in mice, rats, monkeys, premenopausal and postmenopausal patients.

Authors:  Y Tanaka; M Sekiguchi; T Sawamoto; T Hata; Y Esumi; S Sugai; S Ninomiya
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jan-Mar       Impact factor: 2.441

7.  Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients.

Authors:  E A Lien; K Wester; P E Lønning; E Solheim; P M Ueland
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.